论文信息 - Neither acute rejection nor immunosuppressant drug therapy (cyclosporine or tacrolimus) correlates with expression of either CD40 or CD154 on peripheral blood cells among human cardiac transplant patients. - 字舞流文

Neither acute rejection nor immunosuppressant drug therapy (cyclosporine or tacrolimus) correlates with expression of either CD40 or CD154 on peripheral blood cells among human cardiac transplant patients.

A. Castro‐Beiras | J. Muñiz | J. Vazquez-Rodriguez | M. Crespo‐Leiro | N. Domenech | I. Moscoso | M. Paniagua | C. Naya

[1] M. Franco,et al. Expression of CD40 ligand, interferon-gamma and Fas ligand genes in endomyocardial biopsies of human cardiac allografts: correlation with acute rejection. , 2001, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[2] M. Baltzan,et al. Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection. , 2000, Transplantation.

[3] D. Harlan,et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates , 1999, Nature Medicine.

[4] M. Sayegh,et al. Immunosuppressive strategies in transplantation , 1999, The Lancet.

[5] P. Linsley,et al. Prolonged acceptance of concordant and discordant xenografts with combined CD40 and CD28 pathway blockade. , 1998, Transplantation.

[6] P. Ganz,et al. Central role for CD40/CD40 ligand (CD154) interactions in transplant rejection. , 1998, Pediatric transplantation.

[7] R. Mitchell,et al. CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection. , 1997, Transplantation.